ENTA — Enanta Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Enanta Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	335	387	244	249	370
Net Total Accounts Receivable
Net Total Receivables	51.3	23.5	60.8	49	39.6
Prepaid Expenses
Total Current Assets	402	437	319	312	423
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.9	15.6	10.7	29.7	34.7
Long Term Investments
Other Long Term Assets
Total Assets	490	486	439	375	462
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	22.6	24.2	36.2	29.8	62.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	27.3	30.6	39.4	54.1	246
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	462	456	399	321	217
Total Liabilities & Shareholders' Equity	490	486	439	375	462
Total Common Shares Outstanding